Campbell & Co Investment Adviser’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Campbell & Co Investment Adviser's PBH Position: Q2 2026 in Review
Campbell & Co Investment Adviser opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 19,175 shares worth $906K. The stake represents 0.05% of the portfolio and ranks #577 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in PBH as recently as Q3 2025.
Campbell & Co Investment Adviser first reported a position in PBH in Q3 2013 and has held it in 8 quarters since. The position peaked at $3.1M in Q3 2013. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Campbell & Co Investment Adviser held 19,175 shares of Prestige Consumer Healthcare worth $906K as of Q2 2026.
- Prestige Consumer Healthcare was a new Campbell & Co Investment Adviser position in Q2 2026.
- Prestige Consumer Healthcare made up 0.05% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #577 holding.
- Campbell & Co Investment Adviser first reported a position in Prestige Consumer Healthcare in Q3 2013 and has held it in 8 quarters since.
- Campbell & Co Investment Adviser's Prestige Consumer Healthcare position peaked at $3.1M in Q3 2013.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.